X
Xufeng Pan
Researcher at Shanghai Jiao Tong University
Publications - 40
Citations - 713
Xufeng Pan is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Lung cancer & Pneumonectomy. The author has an hindex of 15, co-authored 36 publications receiving 511 citations.
Papers
More filters
Journal ArticleDOI
Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
TL;DR: It is indicated that TRIM65 knockdown attenuates autophagy and cisplatin resistance in A549/DDP cells via regulating miR-138-5p.
Journal ArticleDOI
Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
Pingzhao Zhang,Bizhi Shi,Meng Zhou,Hua Jiang,Hui Zhang,Xufeng Pan,Huiping Gao,Huiru Sun,Zonghai Li +8 more
TL;DR: The results suggest that Gal-1 contributes to both tumorigenesis and cisplatin resistance in EOC and is a potential therapeutic target for EOC.
Journal ArticleDOI
A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma
TL;DR: This study provides meaningful information for deeper understanding the underlying molecular mechanism of lung adenocarcinoma and for evaluating prognosis, which could monitor recurrence, guide clinical treatment drugs and subsequent related researches.
Journal ArticleDOI
Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma
Wen-Yang Jiang,Rui Wang,Xufeng Pan,Yuzhou Shen,Tianxiang Chen,Yunhai Yang,Jin-Cheng Shao,Lei Zhu,Baohui Han,Jun Yang,Heng Zhao +10 more
TL;DR: The prognosis of LELC was satisfactory, and commonly occurred in senior non-smoking women, and the patients with large tumor, accompanied with lymph nodes metastasis or at the advanced stage had the worst OS.
Journal ArticleDOI
Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
TL;DR: Considering sublobar resection better preserves lung function and has reduced overall morbidity, sublobby resection may be preferable for the treatment of young patients with stage IA NSCLC.